CNS vs MAIN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CNS

43.0
AI Score
VS
MAIN Wins

MAIN

46.9
AI Score

Investment Advisor Scores

CNS

43score
Recommendation
HOLD

MAIN

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS MAIN Winner
Forward P/E 18.5874 15.6986 MAIN
PEG Ratio 1.3563 1.7605 CNS
Revenue Growth 11.1% 1.9% CNS
Earnings Growth 0.0% -9.5% CNS
Tradestie Score 43.0/100 46.9/100 MAIN
Profit Margin 28.2% 77.0% MAIN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CNS 1M: +5.0% · 3M: -15.6% MAIN 1M: +5.7% · 3M: -4.1%

Current Technical Phase

CNS

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -5.6%) with fading momentum, RSI 49

RSI (14): 48.8 · Price: $72.33

MAIN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.0 · Price: $56.81

Fundamentals Snapshot

Metric CNS MAIN
Market Cap — —
Forward P/E 19.6 14.6
Trailing P/E 22.7 11.8
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.5% 1.0%
Operating Margin 0.3% 0.9%
EPS 3.25 4.85
Dividend Yield 0.04% 0.05%

Frequently Asked Questions

Based on our detailed analysis, MAIN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.